My Companies
Notification
Account
Log Out
Login
Board approved slump sale of API business to WOS RPG Active Pharma for Rs 33.55 Cr. RPGAP to receive Rs 243.33 Cr from PE investors for ~40% stake (commitment upto Rs 700 Cr for growth) and acquire Actis Generics for Rs 80 Cr.
RPG Life Sciences Partners With InvAscent In ₹243.33 Crore API Investment
RPG Life Sciences Agrees To Acquire Raghava API Business For ₹135 Crore
RPG Life Sciences Approves Up To ₹135 Crore Raghava API Acquisition
RPG Life Sciences Approves ₹135 Crore API Business Acquisition
RPG Life Sciences Carves Out API Business, Raises ₹243 Crore From InvAscent